Clinical trial
Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating…
NCT00445744 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00445744 |
|---|---|
| Title | Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome |
| Official title | Cyclophosphamide Followed by Intravenous Busulfan as Conditioning for Hematopoietic Cell Transplantation in Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome. |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH National Cancer Institute (NCI) |
| Status | Completed |
| Study type | Interventional |
| Conditions | Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13, q22), Adult Acute Myeloid Leukemia With t(15, 17)(q22, q12), Adult Acute Myeloid Leukemia With t(16, 16)(p13 and 17 more |
| Intervention type | Drug, Genetic, Other, Procedure |
| Interventions | cyclophosphamide, busulfan, tacrolimus, methotrexate, cytogenetic analysis, flow cytometry, pharmacological study, pharmacogenomic studies, peripheral blood stem cell transplantation, allogeneic hematopoietic stem cell transplantation |
| Enrollment | 52 |
| Start date | Dec 1, 2006 |
| Primary completion | Jun 1, 2011 |
| Completion | Jun 1, 2013 |
| First posted | Mar 9, 2007 |
| Last update posted | Jan 2, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: